Crossmark

Tumoral BRD4 expression in lymph node-negative breast cancer: association with T-bet+ tumor-infiltrating lymphocytes and disease-free survival

Crossref DOI link: https://doi.org/10.1186/s12885-018-4653-6

Published Online: 2018-07-20

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lee, Minji

Tayyari, Farnoosh

Pinnaduwage, Dushanthi

Bayani, Jane

Bartlett, John M. S.

Mulligan, Anna Marie

Bull, Shelley B.

Andrulis, Irene L. http://orcid.org/0000-0002-4226-6435
License Information

Text and Data Mining valid from 2018-07-20
More Information

Article History

Received: 5 December 2017

Accepted: 29 June 2018

First Online: 20 July 2018

Ethics approval and consent to participate

: Written informed consent was obtained from all study participants. The study was approved by the Research Ethics Board of Mount Sinai Hospital, Toronto, ON, Canada (#01–0313-U), and the University Health Network, Toronto, ON, Canada (#02–0881-C). Specific consent for retrieving the specimen TMA blocks was obtained as part of the previous studies involving the use of this cohort.

: Not applicable.

: Lee, and Drs. Tayyari, Pinnaduwage, Bayani, Bartlett, Mulligan, Bull, Andrulis have no competing interests to declare.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.